Position history for FARALLON CAPITAL MANAGEMENT LLC's holdings in PROTAGONIST THERAPEUTICS INC
FARALLON CAPITAL MANAGEMENT LLC holds 6.3M shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $669.2M as of 2026-Q1. The position was increased (+3.3% shares). PTGX represents 3.8% of FARALLON CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$669.2M
Current Shares
6.3M
Total Value Change
+$466.8M
Total Shares Change
+508,133
Other major holders of PTGX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BlackRock, Inc.
Increased |
| 6.3M |
+3.3% |
| $669.2M |
| 3.8% |
| $91.30 |
60 |
| 2025-Q4 | Decreased | 6.1M | -0.8% | $536.6M | 2.5% | $87.26 | 0 |
| 2025-Q3 | Increased | 6.2M | +0.4% | $411.6M | 1.7% | $65.14 | 49 |
| 2025-Q2 | Increased | 6.2M | +1.1% | $341.1M | 1.5% | $55.69 | 49 |
| 2025-Q1 | Increased | 6.1M | +3.0% | $295.3M | 1.6% | $48.88 | 50 |
| 2024-Q4 | Increased | 5.9M | +1.2% | $228.9M | 1.2% | $38.51 | 49 |
| 2024-Q3 | Increased | 5.9M | +0.3% | $263.7M | 1.3% | $44.56 | 49 |
| 2024-Q2 | Increased | 5.8M | +1.8% | $202.4M | 1.0% | $34.65 | 44 |